Cargando…
PD−L1 immunostaining: what pathologists need to know
BACKGROUND: Immune checkpoint proteins, especially PD-L1 and PD-1, play a crucial role in controlling the intensity and duration of the immune response, thus preventing the development of autoimmunity. These proteins play a vital role in enabling cancer cells to escape immunity, proliferate and prog...
Autores principales: | Akhtar, Mohammed, Rashid, Sameera, Al-Bozom, Issam A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543866/ https://www.ncbi.nlm.nih.gov/pubmed/34689789 http://dx.doi.org/10.1186/s13000-021-01151-x |
Ejemplares similares
-
Correction: PD − L1 immunostaining: what pathologists need to know
por: Akhtar, Mohammed, et al.
Publicado: (2022) -
Ductal Carcinoma In Situ: What the Pathologist Needs to Know and Why
por: Bane, Anita
Publicado: (2013) -
CK20 and CK5/6 Immunohistochemical Staining of Urothelial Neoplasms: A Perspective
por: Akhtar, Mohammed, et al.
Publicado: (2020) -
Tissue management in precision medicine: What the pathologist needs to know in the molecular era
por: Souza da Silva, Ricella, et al.
Publicado: (2022) -
Reproducibility in PD-L1 Immunohistochemistry Quantification through the Tumor Proportion Score and the Combined Positive Score: Could Dual Immunostaining Help Pathologists?
por: Mercier, Anaïs, et al.
Publicado: (2023)